UBE2M and breast cancer: Kaplan-Meier analysis (Kaplan–Meier plotter [Breast] [kmplot.com]) revealed that patients with breast cancer with higher UBE2M expression had lower OS and RFS rates than those with lower UBE2M expression (OS, p = 0.01, HR = 1.28; RFS, p = 0.0038, HR = 1.16) (Figs. S3A and S3B).